Anticoagulant Use During Extracorporeal Membrane Oxygenation Using Heparin and Direct Thrombin Inhibitors in COVID-19 and ARDS Patients

Coagulopathies develop in patients supported with the use of extracorporeal membrane oxygenation (ECMO) and can be hemorrhagic and/or thrombophilic in spite of the use of systemic anticoagulation. The purpose this study was to examine the use of heparin and direct thrombin inhibitors (DTI) in COVID-...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	The Journal of extra-corporeal technology 2022-09, Vol.54 (3), p.223-234
Hauptverfasser:	Stammers, Alfred H, Tesdahl, Eric A, Barletti, Shannon, Mongero, Linda, Patel, Kirti, Mosca, Matthew, Sestokas, Anthony, Firstenberg, Michael S, Jacobs, Jeffrey P
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Anticoagulants - therapeutic use Antithrombins - therapeutic use Bayes Theorem COVID-19 - etiology COVID-19 - therapy Extracorporeal Membrane Oxygenation - adverse effects Heparin - therapeutic use Humans Original Respiratory Distress Syndrome - drug therapy Retrospective Studies
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!